XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Oct. 31, 2020
Oct. 31, 2019
Oct. 31, 2020
Oct. 31, 2019
Income Statement [Abstract]        
Sales-net of slotting fees and discounts $ 9,898,991 $ 9,267,036 $ 31,384,394 $ 24,731,305
Costs of sales 6,773,662 6,366,084 21,317,384 16,767,903
Gross profit 3,125,329 2,900,952 10,067,010 7,963,402
Operating expenses:        
Research and development 30,765 32,744 86,103 82,579
General and administrative 2,307,436 2,364,608 7,411,060 6,446,715
Total operating expenses 2,338,201 2,397,352 7,497,163 6,529,294
Income from operations 787,128 503,600 2,569,847 1,434,108
Other expenses        
Interest (45,822) (89,635) (171,872) (293,531)
Amortization of debt discount (7,164) (5,350) (17,864) (17,988)
Total other expenses (52,986) (94,985) (189,736) (311,519)
Net income before income tax provision 734,142 408,615 2,380,111 1,122,589
Income tax provision
Net income $ 734,142 $ 408,615 $ 2,380,111 $ 1,122,589
Net income per common share - basic $ 0.02 $ 0.01 $ 0.07 $ 0.04
Net income per common share - diluted $ 0.02 $ 0.01 $ 0.07 $ 0.04
Weighted average common shares outstanding - basic 34,225,446 31,991,241 32,832,450 31,935,837
Weighted average common shares outstanding - diluted 35,725,984 32,091,210 34,322,988 32,035,806